Display options
Cite
Blayney DW, Bariani G, Das D, et al. Spotlight on International Quality: COVID-19 and Its Impact on Quality Improvement in Cancer Care. JCO Glob Oncol. 2021;7:1513-1521doi: 10.1200/GO.21.00281.
Blayney, D. W., Bariani, G., Das, D., Dawood, S., Gnant, M., De Guzman, R., Martin, S. E., O'Mahony, D., Roach, A., Ruff, P., Sampaio, C., Sanchez, J. A., Vanderpuye, V., Kamal, A., & Hendricks, C. (2021). Spotlight on International Quality: COVID-19 and Its Impact on Quality Improvement in Cancer Care. JCO global oncology, 71513-1521. https://doi.org/10.1200/GO.21.00281
Blayney, Douglas W, et al. "Spotlight on International Quality: COVID-19 and Its Impact on Quality Improvement in Cancer Care." JCO global oncology vol. 7 (2021): 1513-1521. doi: https://doi.org/10.1200/GO.21.00281
Blayney DW, Bariani G, Das D, Dawood S, Gnant M, De Guzman R, Martin SE, O'Mahony D, Roach A, Ruff P, Sampaio C, Sanchez JA, Vanderpuye V, Kamal A, Hendricks C. Spotlight on International Quality: COVID-19 and Its Impact on Quality Improvement in Cancer Care. JCO Glob Oncol. 2021 Sep;7:1513-1521. doi: 10.1200/GO.21.00281. PMID: 34714666; PMCID: PMC8563078.
Copy Download .nbib Format: NLM
Share it on

JCO Glob Oncol. 2021 Sep;7:1513-1521. doi: 10.1200/GO.21.00281.

Spotlight on International Quality: COVID-19 and Its Impact on Quality Improvement in Cancer Care.

JCO global oncology

Douglas W Blayney, Giovanni Bariani, Devika Das, Shaheenah Dawood, Michael Gnant, Roselle De Guzman, S Eric Martin, Deirdre O'Mahony, Alex Roach, Paul Ruff, Carlos Sampaio, Jose Angel Sanchez, Verna Vanderpuye, Arif Kamal, Carolyn Hendricks

Affiliations

  1. Stanford Cancer Institute, Stanford University, Stanford, CA.
  2. Hospital Sirio Libanes, São Paulo, Brazil.
  3. Hematology Oncology at The Kirklin Clinic of University of Alabama, Birmingham, AL.
  4. Mediclinic City Hospital Dubai, Dubai, United Arab Emirates.
  5. Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  6. Manila Central University-FDTMF Hospital, Caloocan, Philippines.
  7. Medical Oncology Hematology Consultants, Wilmington, DE.
  8. Bon Secours Cork Cancer Centre, Cork, Ireland.
  9. Teladoc Health, Washington, DC.
  10. University of the Witwatersrand, Johannesburg, South Africa.
  11. Clinica AMO Salvador, Brazil.
  12. Hospital Escuela, University of Honduras, Tegucigalpa, Honduras.
  13. National Center for Radiotherapy Oncology and Nuclear Medicine, Accra, Ghana.
  14. Duke University School of Medicine, Durham, NC.
  15. Maryland Oncology Hematology, Bethesda, MD.

PMID: 34714666 PMCID: PMC8563078 DOI: 10.1200/GO.21.00281

Abstract

This report from ASCO's International Quality Steering Group summarizes early learnings on how the COVID-19 pandemic and its stresses have disproportionately affected cancer care delivery and its delivery systems across the world. This article shares perspectives from eight different countries, including Austria, Brazil, Ghana, Honduras, Ireland, the Philippines, South Africa, and the United Arab Emirates, which provide insight to their unique issues, challenges, and barriers to quality improvement in cancer care during the pandemic. These perspectives shed light on some key recommendations applicable on a global scale and focus on access to care, importance of expanding and developing new treatments for both COVID-19 and cancer, access to telemedicine, collecting and using COVID-19 and cancer registry data, establishing measures and guidelines to further enhance quality of care, and expanding communication among governments, health care systems, and health care providers. The impact of the COVID-19 pandemic on cancer care and quality improvement has been and will continue to be felt across the globe, but this report aims to share these experiences and learnings and to assist ASCO's international members and our global fight against the pandemic and cancer.

References

  1. N Engl J Med. 2020 May 21;382(21):1969-1973 - PubMed
  2. N Engl J Med. 2015 Apr 9;372(15):1381-4 - PubMed
  3. N Engl J Med. 2020 Aug 27;383(9):801-803 - PubMed
  4. JCO Glob Oncol. 2021 Jan;7:4-9 - PubMed
  5. JAMA. 2021 Apr 6;325(13):1249-1250 - PubMed
  6. Lancet Oncol. 2020 Aug;21(8):1023-1034 - PubMed
  7. Cancer Cell. 2020 Nov 9;38(5):629-646 - PubMed
  8. mBio. 2020 May 29;11(3): - PubMed

MeSH terms

Publication Types